AVGO vs IONQ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
IONQ exhibits a critically weak financial health profile with a Piotroski F-Score of 1/9, indicating severe fundamental instability despite explosive revenue growth. While the company maintains a strong liquidity position (Current Ratio 15.50) and negligible debt, its valuation is disconnected from current performance, evidenced by an extreme Price/Sales ratio of 121.48. The disconnect between the 'Strong Buy' analyst consensus and the bearish insider selling/technical trend suggests a speculative bubble driven by quantum computing hype rather than fiscal viability.
Compare Another Pair
Related Comparisons
AVGO vs IONQ: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and IonQ, Inc. (IONQ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.